Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst at JPMorgan,…
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst at JPMorgan,…
Truist lowered the firm’s price target on IGM Biosciences (IGMS) to $1 from $2 and keeps a Hold rating on…
Scotiabank lowered the firm’s price target on GitLab (GTLB) to $67 from $80 and keeps an Outperform rating on the…
TD Cowen analyst Derrick Wood lowered the firm’s price target on PagerDuty (PD) to $17 from $18 and keeps a…
Target says that it saw softer-than-expected sales and profit pressures in the first quarter as the retail environment remained “highly…
The price target of Targa Resources Corp. (NYSE:TRGP) was recently lowered by Argus Research. Let’s shed some light on the…